Aurora, CONCT06620302Now EnrollingIRB Ready

Solid Tumors Clinical Trial in Aurora, CO

Access cutting-edge solid tumors treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by Children's Oncology Group

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions...

Expert Care in Aurora

Access solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors treatment provided free

Apply for This Aurora Location

Check if you qualify for this solid tumors clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Solid Tumors Study in Aurora

This phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolescents and young adults with solid tumors and fibrolamellar cancer that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). DT2216 is an anti-apoptotic protein B-cell lymphoma-extra large targeted protein degrader. It may stop the growth of tumor cells by blocking Bcl-xL, a pro

Sponsor: Children's Oncology Group

Who Can Participate

Inclusion Criteria

PHASE 1: Patients between ≥ 1 year and ≤ 21 years of age at the time of study enrollment
PHASE 2: Patients between ≥ 1 year and ≤ 39 years of age at the time of study enrollment
PHASE 1: Patients with recurrent/refractory solid tumors excluding primary central nervous system tumors
PHASE 2: Patients with (FLC), which must include genomic confirmation of the DNAJB1:PRKACA fusion performed at a Clinical Laboratory Improvement Act (CLIA)-certified laboratory
PHASE 1: Patients must have either measurable or evaluable disease
PHASE 2: Patients must have measurable disease
PHASE 1: Patient's current disease state must be one for which there is no known curative therapy or therapy proven to prolong survival with an acceptable quality of life
PHASE 2: Patients must have FLC which is recurrent/refractory to at least one line of prior systemic therapy
Patients with FLC that is unresectable at initial diagnosis but is not recurrent/refractory to at least one

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT06620302) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors Treatment Options in Aurora, CO

If you're searching for solid tumors treatment options in Aurora, CO, this clinical trial (NCT06620302) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Aurora, CO

See all advanced solid tumors clinical trials recruiting in Aurora — not just this study.

Browse Advanced Solid Tumors Trials in Aurora

Browse More Trials by Condition

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO